SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 302 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $68,537,000 | +1864.9% | 396,600 | +1207.4% | 0.52% | +1907.7% |
| Q4 2014 | $3,488,000 | +209.5% | 30,335 | +320.4% | 0.03% | +188.9% |
| Q3 2014 | $1,127,000 | -48.4% | 7,215 | -59.3% | 0.01% | -57.1% |
| Q2 2014 | $2,185,000 | -51.6% | 17,712 | -59.4% | 0.02% | -44.7% |
| Q1 2014 | $4,519,000 | +164.4% | 43,612 | +129.5% | 0.04% | +245.5% |
| Q4 2013 | $1,709,000 | – | 19,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |